MCID: CNT060
MIFTS: 45

Central Serous Chorioretinopathy

Categories: Rare diseases, Immune diseases, Bone diseases, Eye diseases

Aliases & Classifications for Central Serous Chorioretinopathy

MalaCards integrated aliases for Central Serous Chorioretinopathy:

Name: Central Serous Chorioretinopathy 49 55 69
Central Serous Chorioretinopathy After Bone Marrow Transplantation 49
Central Serous Choroidopathy 49
Cscr 55

Characteristics:

Orphanet epidemiological data:

55
central serous chorioretinopathy
Inheritance: Not applicable;

Classifications:

Orphanet: 55  
Rare eye diseases


External Ids:

Orphanet 55 ORPHA443079
UMLS via Orphanet 70 C0730328
ICD10 via Orphanet 33 H35.7
UMLS 69 C0730328

Summaries for Central Serous Chorioretinopathy

NIH Rare Diseases : 49 Central serous chorioretinopathy is a disease that causes fluid to build up under the retina, the back part of the inner eye that sends sight information to the brain. The fluid leaks from the choroid (the blood vessel layer under the retina). The cause of this condition is unknown but stress can be a risk factor. Signs and symptoms include dim and blurred blind spot in the center of vision, distortion of straight lines and seeing objects as smaller or farther away. Many cases of central serous chorioretinopathy improve without treatment after 1-2 months. Laser treatment may be an option for other individuals. Last updated: 1/30/2014

MalaCards based summary : Central Serous Chorioretinopathy, also known as central serous chorioretinopathy after bone marrow transplantation, is related to choroiditis and retinitis. An important gene associated with Central Serous Chorioretinopathy is CFH (Complement Factor H), and among its related pathways/superpathways are Senescence and Autophagy in Cancer and Complement Pathway. The drugs Spironolactone and Eplerenone have been mentioned in the context of this disorder. Affiliated tissues include eye, retina and bone marrow, and related phenotypes are cardiovascular system and renal/urinary system

Related Diseases for Central Serous Chorioretinopathy

Diseases related to Central Serous Chorioretinopathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 96)
# Related Disease Score Top Affiliating Genes
1 choroiditis 31.6 ARMS2 CFH
2 retinitis 10.8
3 retinal detachment 10.5
4 macular degeneration, age-related, 1 10.4
5 aging 10.4
6 endotheliitis 10.3
7 catastrophic antiphospholipid syndrome 10.3 CFH SERPINE1
8 multifocal choroiditis 10.3 ARMS2 CFH
9 retinal drusen 10.3 ARMS2 CFH
10 apnea, obstructive sleep 10.3
11 sleep apnea 10.3
12 kuhnt-junius degeneration 10.2 ARMS2 CFH
13 degeneration of macula and posterior pole 10.2 ARMS2 CFH
14 vogt-koyanagi-harada disease 10.1
15 fibrinolytic defect 10.1 PLAT SERPINE1
16 plasminogen activator inhibitor-1 deficiency 10.1 PLAT SERPINE1
17 argentine hemorrhagic fever 10.1 PLAT SERPINE1
18 angina pectoris 10.1 PLAT SERPINE1
19 carotid artery thrombosis 10.1 PLAT SERPINE1
20 acute cor pulmonale 10.1 PLAT SERPINE1
21 thrombophlebitis 10.1 PLAT SERPINE1
22 acute pulmonary heart disease 10.1 PLAT SERPINE1
23 coronary thrombosis 10.1 PLAT SERPINE1
24 chronic venous insufficiency 10.1 PLAT SERPINE1
25 retinitis pigmentosa 10.1
26 leber congenital amaurosis 4 10.1
27 hydrops, lactic acidosis, and sideroblastic anemia 10.1
28 ulcerative colitis 10.1
29 colitis 10.1
30 uveitis 10.1
31 adrenal gland hyperfunction 10.1
32 pustulosis of palm and sole 10.1
33 retinal degeneration 10.1
34 neuropathy 10.1
35 chorioretinitis 10.1
36 psoriasis 10.1
37 hepatic veno-occlusive disease 10.1 PLAT SERPINE1
38 venous insufficiency 10.0 PLAT SERPINE1
39 thrombophilia due to activated protein c resistance 10.0 PLAT SERPINE1
40 thrombophilia due to thrombin defect 10.0 PLAT SERPINE1
41 afibrinogenemia, congenital 10.0 PLAT SERPINE1
42 disseminated intravascular coagulation 10.0 PLAT SERPINE1
43 pulmonary embolism 10.0 PLAT SERPINE1
44 peripheral vascular disease 10.0 PLAT SERPINE1
45 hallermann-streiff syndrome 9.9
46 arteries, anomalies of 9.9 PLAT SERPINE1
47 hemorrhagic disease 9.9 PLAT SERPINE1
48 gastroesophageal reflux 9.9
49 multiple sclerosis 9.9
50 immune suppression 9.9

Graphical network of the top 20 diseases related to Central Serous Chorioretinopathy:



Diseases related to Central Serous Chorioretinopathy

Symptoms & Phenotypes for Central Serous Chorioretinopathy

MGI Mouse Phenotypes related to Central Serous Chorioretinopathy:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.35 C4B CFH NR3C2 PLAT SERPINE1
2 renal/urinary system MP:0005367 8.92 C4B CFH NR3C2 SERPINE1

Drugs & Therapeutics for Central Serous Chorioretinopathy

Drugs for Central Serous Chorioretinopathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 105)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Spironolactone Approved Phase 4,Phase 2,Phase 3 1952-01-7, 52-01-7 5833
2
Eplerenone Approved Phase 4,Phase 2,Phase 3 107724-20-9 443872 150310
3
Verteporfin Approved, Investigational Phase 4,Phase 1,Phase 2 129497-78-5
4
Ranibizumab Approved Phase 4,Phase 1,Phase 2 347396-82-1 459903
5 diuretics Phase 4,Phase 2,Phase 3
6 Mineralocorticoid Receptor Antagonists Phase 4,Phase 2,Phase 3
7 Mineralocorticoids Phase 4,Phase 2,Phase 3
8 Natriuretic Agents Phase 4,Phase 2,Phase 3
9 Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1
10 Dermatologic Agents Phase 4,Phase 2,Phase 1
11 Angiogenesis Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
12 Hormones Phase 4,Phase 2,Phase 3,Phase 1
13 Angiogenesis Modulating Agents Phase 4,Phase 2,Phase 3,Phase 1
14 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 3
15 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1
16 Photosensitizing Agents Phase 4,Phase 1,Phase 2
17
Bevacizumab Approved, Investigational Phase 2, Phase 3 216974-75-3
18
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
19
Zinc Approved, Investigational Phase 2 7440-66-6 32051 23994
20
Mifepristone Approved, Investigational Phase 2 84371-65-3 55245
21
Ketoconazole Approved, Investigational Phase 2 65277-42-1 3823 47576
22
Omeprazole Approved, Investigational, Vet_approved Phase 1, Phase 2 73590-58-6 4594
23
Finasteride Approved Phase 1, Phase 2 98319-26-7 57363
24
Hydrocortisone Approved, Vet_approved Phase 1, Phase 2 50-23-7 657311 5754
25
Copper Approved, Investigational Phase 2 7440-50-8 27099
26
Selenium Approved, Investigational, Vet_approved Phase 2 7782-49-2
27
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
28
Amoxicillin Approved, Vet_approved Phase 1, Phase 2 26787-78-0 33613 2171
29
Metronidazole Approved Phase 1, Phase 2 443-48-1 4173
30
leucovorin Approved, Nutraceutical Phase 2 58-05-9 143 6006
31
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
32
Vitamin A Approved, Nutraceutical, Vet_approved Phase 2 68-26-8, 11103-57-4 445354
33
Riboflavin Approved, Investigational, Nutraceutical, Vet_approved Phase 2 83-88-5 493570
34
Vitamin C Approved, Nutraceutical Phase 2 50-81-7 54670067 5785
35
Manganese Approved, Nutraceutical Phase 2 7439-96-5 27854
36
Lutein Approved, Investigational, Nutraceutical Phase 2 127-40-2 6433159
37 Tocopherol Approved, Investigational, Nutraceutical Phase 2
38
Vitamin E Approved, Nutraceutical, Vet_approved Phase 2 59-02-9 14985
39
Lactitol Investigational Phase 1, Phase 2 585-86-4 3871
40 Anecortave Investigational Phase 1, Phase 2 10184-70-0
41 Folic Acid Antagonists Phase 2
42 Nucleic Acid Synthesis Inhibitors Phase 2
43 Vitamin B Complex Phase 2
44 Immunosuppressive Agents Phase 2
45 Antimetabolites Phase 2
46 Antimetabolites, Antineoplastic Phase 2
47 Antirheumatic Agents Phase 2
48 interferons Phase 1, Phase 2
49 5-alpha Reductase Inhibitors Phase 1, Phase 2
50 Cathartics Phase 1, Phase 2

Interventional clinical trials:

(show top 50) (show all 57)

# Name Status NCT ID Phase Drugs
1 PRedictive Factors and Changes From Treatment in Idiopathic Polypoidal Choroidal Vasuclopathy Versus Central Serous Chorioretinopathy Versus Neovascular Age Related Macular Degeneration With afLibercept Unknown status NCT02681783 Phase 4 aflibercept
2 Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy Completed NCT01797861 Phase 4
3 Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population Completed NCT02462499 Phase 4 Inspra (eplerenone)
4 Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC) Completed NCT01574430 Phase 4
5 Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy Recruiting NCT03079141 Phase 4 Eplerenone
6 Cohort Study of the Clinical Course of Macular Diseases in Kagawa Recruiting NCT02321267 Phase 4 ranibizumab, aflibercept, pegaptanib, verteporphin
7 A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy Unknown status NCT02215330 Phase 2, Phase 3 Eplerenone;Maltodextrin
8 Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy Unknown status NCT00418431 Phase 2, Phase 3 Intravitreal injection of Bevacizumab
9 Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy Recruiting NCT02735213 Phase 2, Phase 3
10 Methotrexate for Central Serous Chorioretinopathy Treatment Trial Unknown status NCT01633983 Phase 2 Methotrexate;Delayed treatment
11 Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy Unknown status NCT02153125 Phase 2 Eplerenone
12 Short-Term Oral Mifepristone for Central Serous Chorioretinopathy Completed NCT02354170 Phase 2 Mifepristone;Placebo
13 High-dose Antioxidants for Central Serous Chorioretinopathy Completed NCT00963131 Phase 2 antioxidants tablets
14 Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Completed NCT00489840 Phase 1, Phase 2 Anecortave Acetate Sterile suspension 15 mg;Anecortave Acetate
15 Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR) Completed NCT00817245 Phase 1, Phase 2 omeprazole, Amoxicillin, metronidazole
16 The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy Completed NCT01710332 Phase 2 Intravitreal Aflibercept Injection
17 Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy Completed NCT01971190 Phase 2 Intravitreal Aflibercept injection;Sham injection
18 Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy Completed NCT01325181 Phase 1, Phase 2 Verteporfin;ranibizumab
19 A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole Completed NCT00211393 Phase 2 ketoconazole
20 Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Retinopathy Completed NCT00987077 Phase 2
21 Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy Completed NCT01227993 Phase 1, Phase 2 Finasteride
22 Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy Completed NCT00837252 Phase 1, Phase 2 Finasteride
23 Topical Interferon Gamma-1b for Central Serous Chorioretinopathy Completed NCT01468337 Phase 1, Phase 2 Interferon gamma-1b
24 Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC) Completed NCT00211445 Phase 2 verteporfin
25 Endpoint Management Software for Photothermal Stimulation of Macular Diseases Recruiting NCT01975103 Phase 2
26 Eplerenone for Central Serous Chorioretinopathy Active, not recruiting NCT01822561 Phase 2 Eplerenone 50mg
27 Finasteride for Chronic Central Serous Chorioretinopathy Terminated NCT01585441 Phase 2 Finasteride;Placebo
28 Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy Completed NCT00403325 Phase 1 rhuFab V2 [ranibizumab] ( Lucentis )
29 Eye Patch Therapy for Central Serous Retinopathy (CSR) Completed NCT02036632 Phase 1
30 The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy Unknown status NCT01630863
31 The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy Unknown status NCT00864773
32 Selective RPE Laser Treatment (SRT) for Various Macular Diseases Unknown status NCT00403884
33 OCT in Rare Chorioretinal Diseases Unknown status NCT02141308
34 Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy Completed NCT01019668 Verteporfin PDT, half-dose;verteporfin PDT, half-fluence
35 Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy Completed NCT01327170
36 Central Serous Chorioretinopathy: Etiology, Course and Prognosis Completed NCT01378130
37 Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy Completed NCT00803517
38 Eplerenone for the Treatment of Central Serous Chorioretinopathy Completed NCT01990677 25mg Eplerenone;Placebo
39 Persona of Central Serous Chorioretinopathy Completed NCT02819622
40 Selective Retina Therapy With Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients Completed NCT03339856
41 Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC) Completed NCT00802906 bevacizumab
42 Microperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy Completed NCT01434095
43 Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD Completed NCT01880788
44 Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment Completed NCT01610804
45 Evaluation and Treatment of Patients With Retinal Disease Completed NCT00005784
46 Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO Completed NCT01692938
47 Multimodal Imaging in Central Serous Chorioretinopathy Recruiting NCT02889185
48 Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers Recruiting NCT02815176
49 Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina Recruiting NCT02088151
50 Cohort Study of the Clinical Course of Macular Diseases in Japanese Recruiting NCT02081339 ranibizumab, aflibercept, pegaptanib, verteporphin

Search NIH Clinical Center for Central Serous Chorioretinopathy

Genetic Tests for Central Serous Chorioretinopathy

Anatomical Context for Central Serous Chorioretinopathy

MalaCards organs/tissues related to Central Serous Chorioretinopathy:

38
Eye, Retina, Bone Marrow, Bone, Brain, Endothelial, Testes

Publications for Central Serous Chorioretinopathy

Articles related to Central Serous Chorioretinopathy:

(show top 50) (show all 667)
# Title Authors Year
1
Topography-guided identification of leakage point in central serous chorioretinopathy: a base for fluorescein angiography-free focal laser photocoagulation. ( 29301768 )
2018
2
Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy. ( 29429986 )
2018
3
Early Choriocapillaris Changes After Half-Fluence Photodynamic Therapy in Chronic Central Serous Chorioretinopathy Evaluated by Optical Coherence Tomography Angiography: Preliminary Results. ( 29409857 )
2018
4
Response of central serous chorioretinopathy evaluated by multimodal retinal imaging. ( 29303152 )
2018
5
Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group. ( 29439089 )
2018
6
Central serous chorioretinopathy following medial transposition of split lateral rectus muscle for complete oculomotor nerve palsy. ( 29331454 )
2018
7
Sub-internal Limiting Membrane Cavity Following Valsalva Retinopathy Resembling Central Serous Chorioretinopathy. ( 29403598 )
2018
8
Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy. ( 29338130 )
2018
9
Eplerenone Versus Observation in the Treatment of Acute Central Serous Chorioretinopathy: A Retrospective Controlled Study. ( 29442283 )
2018
10
Torpedo maculopathy with multifocal central serous chorioretinopathy: A rare case report. ( 29380797 )
2018
11
CORRELATIONS BETWEEN CHANGES IN PHOTORECEPTOR LAYER AND OTHER CLINICAL CHARACTERISTICS IN CENTRAL SEROUS CHORIORETINOPATHY. ( 29401176 )
2018
12
Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up. ( 29303148 )
2018
13
Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy. ( 29424884 )
2018
14
CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Early and Late Morphological and Functional Changes After Verteporfin Photodynamic Therapy. ( 29346241 )
2018
15
A potential side effect of oral topical steroids: Central serous chorioretinopathy. ( 29442094 )
2018
16
Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study. ( 29359109 )
2018
17
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy. ( 28797227 )
2017
18
Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case. ( 28868032 )
2017
19
Detection of Silent Type I Choroidal Neovascular Membrane in Chronic Central Serous Chorioretinopathy Using En Face Swept-Source Optical Coherence Tomography Angiography. ( 29348931 )
2017
20
Acute lupus choroidopathy: multimodal imaging and differential diagnosis from central serous chorioretinopathy. ( 28050729 )
2017
21
Peripheral Vascular Endothelial Dysfunction in Central Serous Chorioretinopathy. ( 28877318 )
2017
22
Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy. ( 28334414 )
2017
23
Pattern of Contrast Sensitivity Changes in Acute Central Serous Chorioretinopathy. ( 29423320 )
2017
24
Increased Choroidal Vascularity in Central Serous Chorioretinopathy Quantified Using Swept-Source Optical Coherence Tomography. ( 27894511 )
2017
25
Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy. ( 28860700 )
2017
26
Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser. ( 28831603 )
2017
27
The relation of somatotypes and stress response to central serous chorioretinopathy. ( 28875245 )
2017
28
Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy. ( 28850595 )
2017
29
Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy. ( 28814876 )
2017
30
CYSTOID MACULAR EDEMA AND CYSTOID MACULAR DEGENERATION AS A RESULT OF MULTIPLE PATHOGENIC FACTORS IN THE SETTING OF CENTRAL SEROUS CHORIORETINOPATHY. ( 27902539 )
2017
31
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. ( 28053499 )
2017
32
Multimodal assessment of patients with chronic central serous chorioretinopathy. ( 28832738 )
2017
33
Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study. ( 28742138 )
2017
34
Correlation between baseline retinal microstructures in spectral-domain optic coherence tomography and need for early intervention in central serous chorioretinopathy. ( 29354717 )
2017
35
Acute uveal effusion during phacoemulsification with preoperative central serous chorioretinopathy: a case report. ( 28774289 )
2017
36
High-Resolution Imaging of Intraretinal Structures in Active and Resolved Central Serous Chorioretinopathy. ( 28055101 )
2017
37
Central serous chorioretinopathy mimicking as choroiditis. ( 29134698 )
2017
38
Systemic Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy. ( 27929707 )
2017
39
Diagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy. ( 28798899 )
2017
40
Early Focal Laser Photocoagulation in Acute Central Serous Chorioretinopathy: A Prospective, Randomized Study. ( 28728183 )
2017
41
Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC. ( 28328626 )
2017
42
Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis. ( 28076442 )
2017
43
Multimodal Imaging in Central Serous Chorioretinopathy. ( 28823348 )
2017
44
Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy. ( 28709702 )
2017
45
Chronic Central Serous Chorioretinopathy-Like Maculopathy as Atypical Presentation of Chorioretinal Folds. ( 29422860 )
2017
46
Relationship between choroidal blood flow velocity and choroidal thickness in patients with regression of acute central serous chorioretinopathy. ( 28889224 )
2017
47
Photoreceptor assessment using adaptive optics in resolved central serous chorioretinopathy. ( 28832731 )
2017
48
Distinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy on optical coherence tomography angiography and en face optical coherence tomography imaging. ( 28091938 )
2017
49
Pachychoroid pigment epitheliopathy in fellow eyes of patients with unilateral central serous chorioretinopathy. ( 28779008 )
2017
50
Atypical Central Serous Chorioretinopathy. ( 28845331 )
2017

Variations for Central Serous Chorioretinopathy

Expression for Central Serous Chorioretinopathy

Search GEO for disease gene expression data for Central Serous Chorioretinopathy.

Pathways for Central Serous Chorioretinopathy

GO Terms for Central Serous Chorioretinopathy

Biological processes related to Central Serous Chorioretinopathy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of complement activation GO:0030449 9.16 C4B CFH
2 complement activation GO:0006956 8.96 C4B CFH
3 fibrinolysis GO:0042730 8.62 PLAT SERPINE1

Sources for Central Serous Chorioretinopathy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....